Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-cell transcriptome changes in rosacea lesions before and after doxycycline
ChiCTR2200059531Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of doxycycline in papulopustular rosacea (2 arms), sponsored by The Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: Immune cells in lesions, Flushing Assessment Tool and 3 more. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
doxycycline
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on ChiCTR2200059531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059531.